Global Compression Therapy Market Projected to Reach USD 5.85 Billion by 2030

Rising Demand for Lymphedema and Venous Disease Management Driving Sustainable Market Growth

The global Compression Therapy Market is projected to grow from USD 4.48 billion in 2025 to USD 5.85 billion by 2030, reflecting a compound annual growth rate (CAGR) of 5.5%.

This steady expansion mirrors structural shifts across healthcare systems worldwide, including the growing prevalence of chronic venous insufficiency, lymphedema, and post-thrombotic conditions, as well as the increasing importance of long-term edema management in both clinical and home care settings.

Key Clinical and Demographic Drivers

Several macro trends are contributing to sustained market growth:

• Rising global geriatric population
• Increasing incidence of Chronic Venous Insufficiency (CVI)
• Higher rates of cancer-related Lymphedema
• Ongoing prevention and management of Deep Vein Thrombosis (DVT)
• Growth in orthopedic and vascular procedures requiring post-operative compression

As healthcare systems shift toward preventive care and chronic disease management, compression therapy is becoming a standardized component of treatment protocols designed to reduce swelling, improve venous and lymphatic return, and support long-term patient outcomes.

Evolving Technology: From Static Garments to Advanced Pneumatic Compression

The compression therapy landscape includes a broad spectrum of solutions:

• Compression bandages
• Compression stockings (Class I, II, III)
• Compression wraps and braces
• Compression tapes
• Pneumatic Compression Devices

Market segmentation also differentiates between:

• Static Compression Therapy
• Dynamic Compression Therapy

Dynamic and programmable Pneumatic Compression Devices are gaining increased relevance due to their ability to deliver sequential, gradient pressure tailored to patient-specific needs. These systems play an expanding role in managing complex and chronic edema conditions, particularly when integrated into comprehensive care plans.

Regional Trends: Mature Markets and Emerging Growth

North America currently represents the largest share of the compression therapy market, supported by:

• Established reimbursement systems
• Advanced healthcare infrastructure
• High clinical adoption of innovative technologies
• Strong emphasis on chronic disease management

At the same time, the Asia Pacific region is projected to demonstrate the fastest growth rate through 2030, driven by expanding patient populations, increased healthcare investment, and growing awareness of compression therapy benefits.

Emerging markets are expected to create meaningful opportunities for manufacturers, providers, and healthcare systems focused on scalable chronic care solutions.

The Expanding Role of Home-Based Care

One of the most significant developments shaping the market is the growth of Home Care Settings.

As healthcare systems emphasize outpatient management and cost-efficient treatment models, patients are increasingly managing chronic edema conditions outside hospital environments. This shift underscores the importance of:

• Safe and reliable pneumatic compression systems
• Ease of use and patient compliance
• Clinically validated treatment protocols
• Education and long-term monitoring

Compression therapy is transitioning from a hospital-based adjunct to a core component of decentralized chronic care.

Lympha Press: Supporting the Evolution of Compression Therapy

As the global compression therapy market evolves, Lympha Press® continues to support clinicians and patients with advanced pneumatic compression technology designed for both clinical and home use.

For decades, Lympha Press systems have been used worldwide as part of comprehensive treatment plans for:

• Lymphedema management
• Chronic venous insufficiency
• Post-surgical edema
• DVT prevention support
• Chronic swelling associated with vascular and lymphatic disorders

Lympha Press pneumatic compression devices are designed to deliver controlled, sequential pressure through multi-chamber garments, supporting physiological lymphatic and venous flow.

With increasing demand for personalized, evidence-based, and home-compatible solutions, advanced pneumatic systems such as Lympha Press play a central role in modern compression therapy strategies.

Market Challenges and the Path Forward

Despite positive projections, the compression therapy market faces ongoing challenges:

• Variability in product standards across regions
• Differences in reimbursement policies
• Patient compliance barriers
• Pricing pressure within competitive markets

Addressing these challenges requires continued innovation, clinician education, regulatory alignment, and patient-centered design.

Outlook to 2030

The projected growth of the compression therapy market reflects more than economic expansion. It signals a broader transformation in how chronic venous and lymphatic conditions are managed globally.

As healthcare systems continue prioritizing long-term outcomes, quality of life, and home-based care models, compression therapy — particularly advanced pneumatic systems — is expected to remain a foundational component of comprehensive chronic disease management.

Source: Compression Therapy Market – Global Forecasts to 2030, MarketsandMarkets™, May 2025.